中国医药(600056.SH)：向专业投资者公开发行公司债券获得注册批复

Core Viewpoint - China Medical (600056.SH) has received approval from the China Securities Regulatory Commission to publicly issue corporate bonds totaling up to 2 billion yuan to professional investors [1] Group 1 - The company will hold its 2024 annual shareholders' meeting on May 16, 2025, to review and approve the proposal for the issuance of corporate bonds and ultra-short-term financing bills [1] - The approval from the regulatory authority allows the company to issue bonds within a validity period of 24 months from the date of registration [1] - The total face value of the corporate bonds that can be issued is capped at 2 billion yuan [1]